Literature DB >> 32970130

Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge.

Jie Liu1, Jinming Yu1, Xue Meng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32970130     DOI： 10.1001/jamaoncol.2020.3955

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  COVID-19-related mortality in cancer patients in an Irish setting.

Authors:  Anna Linehan; Orla Fitzpatrick; Darren Cowzer; Maeve A Hennessy; Zac L Coyne; Amy Nolan; Maeve Clarke; Roisin Ni Dhonaill; Bryan T Hennessy; Patrick G Morris; Liam Grogan; Oscar Breathnach
Journal:  Ir J Med Sci       Date:  2021-10-25       Impact factor: 2.089

2.  Outcomes of elective head and neck confirmed or suspected cancer surgery during the COVID-19 pandemic.

Authors:  Sabrina Brar; Enyi Ofo; Nicholas Hyde; Dae Kim; Tunde Odutoye; David Allin; Aleix Rovira
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-15       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.